Effectiveness And Safety Of Uchasingihwan For Low Back Pain Due To Lumbar Disc Herniation
                                                    Effectiveness And Safety Of Uchasingihwan For Low Back Pain Due To Lumbar Disc Herniation
Clinical research on the effectiveness and safety of Uchasingihwan for low back pain with radiculopathy caused by herniated intervertebral disc of the lumbar spine: A multicenter, randomized, controlled equivalence trial.
Integr Med Res . 2024 Dec;13(4):101090.Synopsis
Seventy-four patients with low back pain with radiculopathy from lumbar herniated intervertebral disc were randomized to receive either UCSGH (n=37) or loxoprofen (n=36) for six weeks, along with weekly acupuncture treatments for both groups. The primary outcome was the change in low back pain as measured by the 100-mm VAS. Secondary outcomes included radiating pain, function (ODI and RMDQ), quali...
                To view the full content, login to your account,
or start your 30-day FREE Trial today.
            
            FREE TRIAL
            LOGIN
            Forgot Password?
    Explore some of our unlocked ACE Reports below!
                Learn about our AI Driven 
 High Impact Search Feature
    Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
                    
                
                                                        
                                                        
                                    LOGIN
                                
            
Join the Conversation
Please Login or Join to leave comments.